| Autor: |
Ahmet EVLİCE, Turgay DEMİR, Hacer BOZDEMİR, Kezban ASLAN |
| Jazyk: |
angličtina |
| Rok vydání: |
2016 |
| Předmět: |
|
| Zdroj: |
Archives of Epilepsy, Vol 22, Iss 2, Pp 51-54 (2016) |
| Druh dokumentu: |
article |
| ISSN: |
2792-0550 |
| DOI: |
10.14744/epilepsi.2016.18894 |
| Popis: |
Objectives:The present study evaluated neurocognitive profile of patients with epilepsy treated with carbamazepine (CBZ) and valproic acid (VPA).Methods:Epilepsy patients who were treated with CBZ and VPA at outpatient clinic between 2013 and 2015 and a healthy control group were included in the study. Neurocognitive findings (mini-mental state examination [MMSE], clock-drawing test, verbal and visual memory tests, digit span test, verbal fluency test) of the groups were compared.Results:Thirty patients with epilepsy treated with CBZ (n=17) and VPA (n=13) and healthy control group (n=21) were included in the study. Clock drawing test score was lower in CBZ group (p=0.024) and forward digit span test score was lower in VPA group (p=0.039) than the healthy controls. There was no significant difference in neurocognitive findings between CBZ and VPA groups.Conclusion:The lack of difference in cognitive findings between CBZ and VPA groups suggests that when beginning treatment, the choice of antiepileptic drug should be determined based on type of seizure. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
